Hyaluronan dry powder inhalation (TFF Pharmaceuticals)

透明质酸干粉吸入剂 (TFF Pharmaceuticals)

Report date: 2025/12/12 17:32:09

Base Information

Drug NameHyaluronan dry powder inhalation (TFF Pharmaceuticals)
Drug Alias NameTFF-HMW-HA
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionHyaluronic acid replacements
TargetsHyaluronic acid
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveRespiratory Tract DiseasesRespirovirus Infections +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTff Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTff Pharmaceuticals IncNational Institute Of Environmental Health Sciences (Niehs)
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveRespirovirus InfectionsRespiratory Syncytial Virus Infections +[5] 
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A